Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Sep 2, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-08-31$0.62/sh−301$186→ 168,143 total
4 · Nabriva Therapeutics plc · Filed Sep 2, 2020
Ordinary Shares